Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for ProPhase Labs (PRPH) over the last 13 years, with Q3 2025 value amounting to $3.7 million.

  • ProPhase Labs' Cash from Financing Activities rose 3004.89% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 2774.46%. This contributed to the annual value of $14.2 million for FY2024, which is 14639.57% up from last year.
  • As of Q3 2025, ProPhase Labs' Cash from Financing Activities stood at $3.7 million, which was up 3004.89% from $261000.0 recorded in Q2 2025.
  • ProPhase Labs' Cash from Financing Activities' 5-year high stood at $40.6 million during Q1 2021, with a 5-year trough of -$9.5 million in Q4 2022.
  • In the last 5 years, ProPhase Labs' Cash from Financing Activities had a median value of $1.4 million in 2023 and averaged $1.9 million.
  • Per our database at Business Quant, ProPhase Labs' Cash from Financing Activities crashed by 155757.58% in 2021 and then skyrocketed by 1143829.79% in 2024.
  • ProPhase Labs' Cash from Financing Activities (Quarter) stood at -$962000.0 in 2021, then crashed by 887.32% to -$9.5 million in 2022, then surged by 130.79% to $2.9 million in 2023, then rose by 27.19% to $3.7 million in 2024, then rose by 0.08% to $3.7 million in 2025.
  • Its Cash from Financing Activities was $3.7 million in Q3 2025, compared to $261000.0 in Q2 2025 and $2.0 million in Q1 2025.